Literature DB >> 15109768

Solid lipid nanoparticles for parenteral drug delivery.

S A Wissing1, O Kayser, R H Müller.   

Abstract

This review describes the use of nanoparticles based on solid lipids for the parenteral application of drugs. Firstly, different types of nanoparticles based on solid lipids such as "solid lipid nanoparticles" (SLN), "nanostructured lipid carriers" (NLC) and "lipid drug conjugate" (LDC) nanoparticles are introduced and structural differences are pointed out. Different production methods including the suitability for large scale production are described. Stability issues and drug incorporation mechanisms into the particles are discussed. In the second part, the biological activity of parenterally applied SLN and biopharmaceutical aspects such as pharmacokinetic profiles as well as toxicity aspects are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109768     DOI: 10.1016/j.addr.2003.12.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  176 in total

1.  In vivo sustained release of siRNA from solid lipid nanoparticles.

Authors:  Tatsiana Lobovkina; Gunilla B Jacobson; Emilio Gonzalez-Gonzalez; Robyn P Hickerson; Devin Leake; Roger L Kaspar; Christopher H Contag; Richard N Zare
Journal:  ACS Nano       Date:  2011-11-18       Impact factor: 15.881

2.  Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization.

Authors:  Yan Li; Jinkai Zheng; Hang Xiao; David Julian McClements
Journal:  Food Hydrocoll       Date:  2011-09-17       Impact factor: 9.147

Review 3.  Nanoparticulate systems for drug delivery and targeting to the central nervous system.

Authors:  Emanuela Fabiola Craparo; Maria Luisa Bondì; Giovanna Pitarresi; Gennara Cavallaro
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

Review 4.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 5.  The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

Authors:  Svetlana Gelperina; Kevin Kisich; Michael D Iseman; Leonid Heifets
Journal:  Am J Respir Crit Care Med       Date:  2005-09-08       Impact factor: 21.405

6.  Steering the Clinical Translation of Delivery Systems for Drugs and Health Products.

Authors:  Rosario Pignatello; Pietro Matricardi
Journal:  Pharmaceutics       Date:  2020-04-13       Impact factor: 6.321

7.  Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.

Authors:  Samuel V Mussi; Rupa Sawant; Federico Perche; Mônica C Oliveira; Ricardo B Azevedo; Lucas A M Ferreira; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

Review 8.  Nanostructured materials for applications in drug delivery and tissue engineering.

Authors:  Michael Goldberg; Robert Langer; Xinqiao Jia
Journal:  J Biomater Sci Polym Ed       Date:  2007       Impact factor: 3.517

9.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

10.  Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.

Authors:  Ketan Hippalgaonkar; Goutham R Adelli; Kanchan Hippalgaonkar; Michael A Repka; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.